Search Results

192,975 Results for "i mab".

Sort By

Press Releases

I-Mab to Participate at the Piper Sandler Healthcare Conference

November 21, 2024
·
1 min read
Press Releases

I-Mab Reports Third Quarter 2024 Results

November 15, 2024
·
17 min read
Business

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.

June 6, 2024
·
5 min read
Press Releases

I-Mab to Participate at the Truist Securities BioPharma Symposium

October 28, 2024
·
1 min read
BioCapital

I-Mab to Participate at the 2024 Jefferies Global Healthcare Conference

I-Mab, a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.

May 22, 2024
·
1 min read
Press Releases

I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

November 6, 2024
·
5 min read
Press Releases

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

November 1, 2024
·
1 min read
BioCapital

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

I-Mab announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.

April 5, 2024
·
1 min read
Press Releases

I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024

October 30, 2024
·
2 min read
Business

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer.

June 5, 2024
·
6 min read